NRG-GI008, the CIRCULATE NA Study, with Drs. Dasari and George

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/60/e8/af/60e8af10-bdff-df62-65d2-b67a544373d1/mza_13084884134369712645.jpg/600x600bb.jpg

The NRG Oncology Podcast

NRG Oncology

34 episodes

2 days ago

The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.

Medicine

Health & Fitness

RSS

All content for The NRG Oncology Podcast is the property of NRG Oncology and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/41380161/41380161-1742999112527-598998ab84715.jpg

NRG-GI008, the CIRCULATE NA Study, with Drs. Dasari and George

The NRG Oncology Podcast

29 minutes 35 seconds

8 months ago

NRG-GI008, the CIRCULATE NA Study, with Drs. Dasari and George

Our co-hosts discuss the currently active & accruing NRG-GI008 study, also known as the "CIRCULATE-NORTH AMERICA" study. This study will evaluate what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.